76 Works

Culture of SARS-CoV-2 in a panel of laboratory cell lines

Wurtz Nathalie, Gwilherm Penant & Bernard La Scola

Hydroxychloroquine recommendations toward the world : first evaluations

Yanis ROUSSEL & Didier RAOULT

Epidemiological surveillance of respiratory viral infections at IHU Méditerranée Infection and its application to SARS-CoV-2

Philippe COLSON, Audrey GIRAUD-GATINEAU & Didier RAOULT

COVID Re-infection

Philippe BROUQUI, Philippe COLSON & Didier RAOULT

Severity of COVID-19 infection and different SARS-CoV-2 variants: current evidence

Thi Loi DAO, Van Thuan HOANG & Matthieu MILLION

What neo semeiology brings to the care of patient with COVID-19.

Philippe BROUQUI, Carole ELDIN, Sophia BOUDJEMA & Didier RAOULT

Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates

Céline BOSCHI & Marion LE BIDEAU

Spreading of a new SARS-CoV-2 N501Y spike clone in a new lineage.

Philippe Colson, Anthony Levasseur & Didier Raoult

Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 2 Outpatients: A Monocentric Retrospective Cohort Study

Matthieu Million, Jean-Christophe Lagier & Hervé Tissot-Dupont

Emergence and outcome of the SARS-CoV-2 “Marseille-4” variant

Pierre-Edouard Fournier

The War Against Chloroquine

Yanis Roussel, Philippe Gautret & Didier Raoult

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)

Didier RAOULT, Matthieu Million, Philippe Gautret , Jean-Christophe Lagier , Philippe Colson , Philippe Parola & Jean-Marc Rolain

Living SARS-CoV-2 in feces suggesting possible fecal-oral contamination

Bernard La Scola, Valérie Moal & Julie Dergham

Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677 in various 7 lineages in Marseille, France

Philippe Colson, Jeremy Delerce & Didier Raoult

Two-millennia fighting against port-imported epidemics, Marseille

REMI BARBIERI, Philippe COLSON, Didier RAOULT & Michel DRANCOURT

New Institute to fight threats: the COVID-19 paradigm

Philippe BROUQUI, Michel DRANCOURT & Didier RAOULT

Consequences of the COVID-19 outbreak on the diversity of non-viral infectious agents and the evolution of antibiotic resistance by using a syndromic surveillance based on laboratory data at the IHU Méditerranée Infection, Marseille, France

Lancei KABA, Audrey GIRAUD-GATINEAU, Marie-Thèrese JIMENO, Jean-Marc ROLAIN, Philippe COLSON, Didier RAOULT & Herve CHAUDET

Remdesivir could promote the occurrence of SARS-COV-2 variants

Philippe COLSON, Christian A. DEVAUX & Didier RAOULT

Isolation of variable SARS-COV-2 in feces suggesting possible fecal transmission of COVID-19

Julie DERGHAM, Jeremy DELERCE & Valérie MOAL

Evaluation of strategies to fight COVID-19. The French paradigm

Audrey GIRAUD-GATINEAU, Philippe GAUTRET & Didier RAOULT

Do remdesivir and plasma therapy favor long-term SARS-CoV-2 infection and mutations in immunocompromised patients?

Philippe GAUTRET, Jean Christophe LAGIER & Didier RAOULT

Who would accept a randomized trial in the context of covid-19?

Hervé TISSOT-DUPONT & Didier RAOULT

SARS-CoV-2 antibodies seroprevalence in dogs from France using ELISA and an 3 automated western blotting assay

Younes Laidoudi & Bernard Davoust

Does remdesivir favor long-term SARS-CoV-2 infection and mutations in immunocompromised patients?

Philippe GAUTRET, Jean Christophe LAGIER & Didier RAOULT

Registration Year

  • 2022
    1
  • 2021
    56
  • 2020
    19

Resource Types

  • Text
    76

Affiliations

  • Aix-Marseille University
    76
  • Méditerranée Infection Foundation
    71
  • Marseille Public University Hospital System
    29
  • French Defence Health Service
    1
  • Institut de Recherche pour le Développement
    1
  • Institut Gustave Roussy
    1
  • Thai Binh University of Medicine and Pharmacy
    1